A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202

被引：0
|
作者：
Syma Iqbal
Cathryn Rankin
Heinz-Josef Lenz
Philip J. Gold
Syed A. Ahmad
Anthony B. El-Khoueiry
Michael J. Messino
Randall F. Holcombe
Charles D. Blanke
机构：
[1] University of Southern California,Norris Comprehensive Cancer Center
[2] Southwest Oncology Group Statistical Center,Barrett Center, Department of Surgery
[3] Swedish Cancer Institute,undefined
[4] University of Cincinnati,undefined
[5] Southeast Cancer Control Consortium,undefined
[6] Inc. CCOP,undefined
[7] Cancer Care of WNC,undefined
[8] University of California at Irvine,undefined
[9] Chao Family CCC,undefined
[10] University of British Columbia,undefined
[11] and British Columbia Cancer Agency,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2011年 / 68卷
关键词：
Gemcitabine; Capecitabine; Cholangiocarcinoma; Gallbladder; Clinical trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1595 / 1602
页数：7
相关论文
共 50 条
  • [31] A phase II study of gemcitabine and capecitabine in advanced cholangiocarcinoma and carcinoma of the gallbladder: A single-institution prospective study
    Iyer, Renuka V.
    Gibbs, John
    Kuvshinoff, Boris
    Fakih, Marwan
    Kepner, James
    Soehnlein, Nancy
    Lawrence, David
    Javle, Milind M.
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (11) : 3202 - 3209
  • [32] A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer
    Hong Suk Song
    Young Rok Do
    Heung Moon Chang
    Min Hee Ryu
    Kyung Hee Lee
    Yeul Hong Kim
    Dae Sik Hong
    Jae Yong Cho
    Kyoung Eun Lee
    Si Young Kim
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 763 - 768
  • [33] A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer
    Song, Hong Suk
    Do, Young Rok
    Chang, Heung Moon
    Ryu, Min Hee
    Lee, Kyung Hee
    Kim, Yeul Hong
    Hong, Dae Sik
    Cho, Jae Yong
    Lee, Kyoung Eun
    Kim, Si Young
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (05) : 763 - 768
  • [34] Capecitabine (X) and etoposide (E) for patients (pts) with locally advanced or metastatic gastric cancer: a Mexican Oncology Study Group phase II trial
    Aldaco, F.
    Reyes, S.
    Tellez, E.
    Torrecillas, L.
    Soto, C.
    Fernandez, R.
    Garcia-Juarez, R.
    Cervantes, G.
    Saenz, J.
    Capdeville, D.
    EJC SUPPLEMENTS, 2005, 3 (02): : 215 - 215
  • [35] Phase II trial of trimetrexate in advanced esophageal cancer: A Southwest Oncology Group Study
    Fleming, TR
    Brown, TD
    Ross, SW
    Macdonald, JS
    INVESTIGATIONAL NEW DRUGS, 1995, 13 (04) : 363 - 365
  • [36] A phase II trial of piroxantrone in endometrial cancer: Southwest Oncology Group study 8918
    Malviya, VK
    Liu, PY
    Goldberg, DA
    Hantel, A
    OToole, RV
    Roach, RW
    Conrad, ME
    Alberts, DS
    ANTI-CANCER DRUGS, 1996, 7 (05) : 527 - 530
  • [37] Phase II trial of topotecan in advanced gastric cancer: A Southwest Oncology Group study
    Benedetti, JK
    Burris, HA
    Balcerzak, SP
    Macdonald, JS
    INVESTIGATIONAL NEW DRUGS, 1997, 15 (03) : 261 - 264
  • [38] A phase II study of IV gemcitabine (G) and oral capecitabine (C) in patients (pts) with advanced renal cell cancer (RCC): Results of Southwest Oncology Group study 0312
    Van Veldhuizen, P. J.
    Hussey, M.
    Lara, P. N.
    Gumerlock, P. H.
    Clark, J.
    Lange, M. K.
    Crawford, E. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [39] Phase II trial of biweekly gemcitabine and paclitaxel with recurrent or metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group study S0329
    Malhotra, Binu
    Moon, James
    Kucuk, Omar
    Clark, Joseph I.
    Urba, Susan G.
    Wolf, Gregory T.
    Worden, Francis P.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2014, 36 (12): : 1712 - 1717
  • [40] Phase II trial of topotecan in advanced gastric cancer: A Southwest Oncology Group study
    Jacqueline K. Benedetti
    Howard A. Burris III
    Stanley P. Balcerzak
    John S. Macdonald
    Investigational New Drugs, 1997, 15 : 261 - 264
12345